DRAVET SYNDROME
Clinical trials for DRAVET SYNDROME explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New epilepsy drug shows promise in long-term safety trial for rare seizure disorders
Disease control CompletedThis study looked at the long-term safety of an experimental drug called LP352 in people aged 12 to 65 with severe epilepsy syndromes like Dravet and Lennox-Gastaut. All 41 participants had already completed an earlier study and continued treatment for up to 52 weeks. Researchers…
Matched conditions: DRAVET SYNDROME
Phase: PHASE2 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 10:29 UTC
-
New hope for rare seizure sufferers: Long-Term drug safety confirmed
Disease control CompletedThis study looked at the long-term safety of a drug called fenfluramine (ZX008) for people with rare seizure disorders like Dravet syndrome and Lennox-Gastaut syndrome. Over 400 participants who had already been in earlier studies took the drug for an extended period. The main go…
Matched conditions: DRAVET SYNDROME
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated May 26, 2026 10:26 UTC
-
Virtual therapy helps kids with rare epilepsy do daily tasks
Symptom relief CompletedThis study tested whether remote occupational therapy could help children and teens with Dravet syndrome improve their daily living skills. Fourteen families participated in online therapy sessions using the CO-OP approach. The goal was to see if telehealth could make therapy mor…
Matched conditions: DRAVET SYNDROME
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Symptom relief
Last updated May 26, 2026 10:30 UTC
-
Healthy volunteers help test Easier-to-Take seizure drug
Knowledge-focused CompletedThis study tested two versions of the seizure drug stiripentol (capsules vs. a liquid suspension) in 24 healthy adults to see if they work the same in the body. The goal is to offer a more convenient option for people with Dravet syndrome, a severe childhood epilepsy. Participant…
Matched conditions: DRAVET SYNDROME
Phase: PHASE1 • Sponsor: Biocodex • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC